UW biotech spinout raises $5M to develop gene therapy system for muscular dystrophy The news: Myosana Therapeutics, a Seattle startup developing gene therapy technology, raised $5 million to develop an early-stage candidate treatment… Read More
Seattle biotech company is the first to receive approval to test B cell gene therapy in humans Seattle biotech startup Immusoft has received approval to begin clinical trials of its novel strategy for treating genetic disease, the… Read More
Gov. Inslee helps Bluebird Bio open new ‘nest’ for cancer research efforts in Seattle Bluebird Bio is growing its nest in Seattle. The leading biotech company held a ribbon-cutting event Friday to celebrate the… Read More
Former Juno execs unveil Sana, a new cell engineering biotech that’s reportedly raising more than $800M Former Juno Therapeutics executives Hans Bishop and Steve Harr have launched Sana Biotechnology, a startup focused on cell therapy, gene… Read More
Newly-developed ‘gene therapy in a box’ could save millions of lives Gene therapy — the process of genetically altering cells to treat disease — is a highly promising process being studied as… Read More
